Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference taking place on April 29-30 features a mix of industry perspectives from experts, including Daniel Snyder of Revance Therapeutics, Inc. His session, “KOL Mapping: Innovative...
Michael Sullivan, an expert in sales training, is presenting at Q1 Production’s 9th Annual Pharmaceutical Sales Training Conference in March. He provided Q1 an early preview of his presentation, “Practical Strategy for Maximizing Remote Training through Enhanced...
Find What Works For You Keeping Up with Technology in Stability Testing Technology is always changing. From new cell phones that help you connect to rockets that go out in to the universe. Technology empowers people to be innovative and create the best results....
Data Integrity While Building Stability Testing Program An Interview With Madhavi Mahavadi Many industries require discretion and integrity. Stability testing is no different. One of the hottest topics in the stability industry is data integrity. Although this is not...
Understanding and Incorporating ICH E6(R2) In November 2016, ICH published an addendum to its guidelines for clinical practice, prompting pharmaceutical companies to align current clinical quality procedures with a risk-based monitoring approach. What was previously a...
Have You Secured Coverage in 2018? How PBMs Hold the Key to Pharmaceutical Success Recent debates surrounding drug pricing have forced the pharmaceutical industry to navigate multiple avenues ensuring optimal coverage while maintaining high levels of ROI. Though the...
